Integral Health Asset Management’s Roivant Sciences ROIV Stock Holding History

Integral Health Asset Management’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$70.8M	Hold	2,000,000	–	–	2.8%	9
2026 Q1	$55.4M	Buy	2,000,000 +1,150,000	+135%	+$29.5M	2.65%	9
2025 Q4	$18.4M	Buy	850,000 +100,000	+13%	+$1.97M	0.92%	38
2025 Q3	$11.3M	Buy	750,000 +150,000	+25%	+$1.86M	0.77%	43
2025 Q2	$6.76M	Hold	600,000	–	–	0.62%	45
2025 Q1	$6.05M	Buy	+600,000	New	+$6.49M	0.64%	46
2024 Q3	–	Sell	-400,000	Closed	-$4.23M	–	94
2024 Q2	$4.23M	Sell	400,000 -200,000	-33%	-$2.19M	0.4%	58
2024 Q1	$6.32M	Buy	+600,000	New	+$6.47M	0.59%	61
2023 Q4	–	Sell	-450,000	Closed	-$5.26M	–	89
2023 Q3	$5.26M	Buy	+450,000	New	+$5.09M	0.73%	49

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Integral Health Asset Management's ROIV Position: Q2 2026 in Review

Integral Health Asset Management held its Roivant Sciences (ROIV) position steady in Q2 2026 at 2,000,000 shares worth $70.8M. The position accounts for 2.8% of the portfolio, ranked #9.

Integral Health Asset Management first reported a position in ROIV in Q3 2023 and has held it in 9 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

Integral Health Asset Management held 2,000,000 shares of Roivant Sciences worth $70.8M as of Q2 2026.
Integral Health Asset Management left its Roivant Sciences share count unchanged in Q2 2026.
Roivant Sciences made up 2.8% of Integral Health Asset Management's portfolio in Q2 2026, its #9 holding.
Integral Health Asset Management first reported a position in Roivant Sciences in Q3 2023 and has held it in 9 quarters since.
498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Integral Health Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.